• Olga Krylova, Sevara Marchenko, Alexandra Ermolaeva, Natalia Shustikova, and Kristina Dyakonova.
• Olga Krylova Associate Professor, Department of Pharmacy, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
• Pak J Med Sci. 2024 Sep 1; 40 (8): 185318591853-1859.

ObjectiveGoal of the study was to systematically review competitive advantages of medical devices for glucose monitoring in diabetic patients.MethodThe review is done systematically according to SALSA criteria and PRISMA guidelines. The search for eligible articles was held from February 16th 2023 to March 1st 2023 in Russian and English languages. The results were synthesized narratively, tabularly, and visually. The search was conducted in the following databases of scientific literature: PubMed, IEEE Xplore, Google Scholar, CyberLeninka, and eLibrary.ResultsTwenty-two out of fifty-two manuscripts met the inclusion criteria. The most promising and advantageous characteristics of the evaluated devices, as identified by researchers, include the following: the capability for noninvasive examination; features that facilitate use by patients with fine motor, hearing, and visual impairments; add-ons and software designed to improve patient compliance, including in pediatric populations; and device attributes that enhance the speed and accuracy of analysis while being free of iatrogenic effects.ConclusionsWith increasing prevalence of diabetes, glycemic control is crucial for preventing complications. The market offers numerous glucose monitoring devices (GMDs) with varying features, making selection challenging. Our study systematically categorized the strengths of each GMD model for diabetic patients, aiding informed device selection.Copyright: © Pakistan Journal of Medical Sciences.

6 keywords...

hide…